相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic Value of Plasma hPG80 (Circulating Progastrin) in Metastatic Renal Cell Carcinoma
Manish Kohli et al.
CANCERS (2021)
A novel method to detect hPG80 (human circulating progastrin) in the blood
Monica Cappellini et al.
ANALYTICAL METHODS (2021)
Neuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence
Aman Chauhan et al.
JAMA ONCOLOGY (2020)
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
Anna Malczewska et al.
ADVANCES IN MEDICAL SCIENCES (2020)
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
Benoit You et al.
EBIOMEDICINE (2020)
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management
Zu-Yi Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Gastrointestinal neuroendocrine tumors in 2020
Monjur Ahmed
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers
Aura D. Herrera-Martinez et al.
ENDOCRINE-RELATED CANCER (2019)
Pan-cancer analysis of somatic mutations across 21 neuroendocrine tumor types
Yanan Cao et al.
CELL RESEARCH (2018)
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
Guido Rindi et al.
MODERN PATHOLOGY (2018)
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Bryan Oronsky et al.
NEOPLASIA (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer
Alexandre Prieur et al.
CLINICAL CANCER RESEARCH (2017)
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Roel Nusse et al.
CELL (2017)
Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem-like Cells
Julie Giraud et al.
CANCER RESEARCH (2016)
Consensus on biomarkers for neuroendocrine tumour disease
Kjell Oberg et al.
LANCET ONCOLOGY (2015)
Age and Cancer Risk A Potentially Modifiable Relationship
Mary C. White et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2014)
Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment
Annemiek Walenkamp et al.
ENDOCRINE-RELATED CANCER (2014)
Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours
Xiuli Jiang et al.
NATURE COMMUNICATIONS (2014)
Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors
Ji Tae Kim et al.
CARCINOGENESIS (2013)
Chromogranin A-Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
Irvin M. Modlin et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Prohormone convertases 1/3 and 2 together orchestrate the site-specific cleavages of progastrin to release gastrin-34 and gastrin-17
Jens F. Rehfeld et al.
BIOCHEMICAL JOURNAL (2008)
β-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors
Julie Pannequin et al.
GASTROENTEROLOGY (2007)
Adherens junctions and tight junctions are regulated via different pathways by progastrin in epithelial cells
F Hollande et al.
JOURNAL OF CELL SCIENCE (2003)
Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma
RK Siddheshwar et al.
GUT (2001)
Gastrin as a growth factor in the gastrointestinal tract
TJ Koh et al.
REGULATORY PEPTIDES (2000)
分享论文
